Arcoma

Arcoma Debt / Assets

Debt-to-Assets Ratio of Arcoma (ARCOMA.ST) as of Oct 24, 2026.

Debt / Assets

0.00

YoY

26.99%

Last updated:

Debt-to-Assets Ratio of Arcoma is 2025 0.00 . Debt-to-Assets Ratio of Arcoma was 2024 0.00 . It decreases by 26.99% higher compared to the previous year.

The Arcoma Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2018
0.18 SEK
Jan 1, 2019
0.09 SEK
Jan 1, 2020
0.18 SEK
Jan 1, 2021
0.21 SEK
Jan 1, 2022
0.25 SEK
Jan 1, 2023
0.05 SEK
Jan 1, 2024
0.00 SEK
Jan 1, 2025
0.00 SEK
The Arcoma Debt / Assets history
YEARDebt / AssetsYoY
0.00+26.99%
0.00-98.45%
0.05-81.11%
0.25+19.35%
0.21+17.08%
0.18+105.02%
0.09-50.13%
0.18+565.26%
0.03-88.49%
0.23+46.72%
0.16-1.72%
0.16—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Arcoma since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Arcoma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Arcoma

All Key Metrics — Arcoma